It is driven by the increasing prevalence of UCDs. The global urea cycle disorder (UCD) treatment market is projected to grow ...
Marshall L. Summar M.D. The urea cycle was first described in 1932 by Krebs and Henseleit [1] (Figure 36.1). The urea cycle disorders (UCD) result from defects in the metabolism of the extra nitrogen ...
Sandra A. Banta-Wright, MN, RNC, NNP; Robert D. Steiner, MD Neonates with profound and prolonged hyperammonemia with coma due to urea cycle defect will have had a neurological insult to the brain ...
The company’s most advanced candidate therapy, SYNB1020, targets hyperammonemia in individuals born with urea cycle disorders (UCDs). It has been given both Orphan Drug and Fast Track ...